drugset / Trial / NCT00962390

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia

NCT00962390

Phase 2 Completed 116 enrolled Ausio Pharmaceuticals, LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and effectiveness of S-equol in men with benign prostatic hyperplasia.

Timeline

Start
2009-06
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AUS-131 Small molecule 10 mg
Subject AUS-131 Small molecule 50 mg
Subject AUS-131 Small molecule 150 mg